A novel approach to left atrial appendage exclusion: The WATCHMAN device

Alexander Gorodnitskiy, Richard J. Lucariello, Anthony Aizer, John T. Coppola

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Atrial fibrillation (AF), a very common cardiac arrhythmia, is a well-recognized predisposing factor for embolic stroke. While warfarin remains the cornerstone of anticoagulant treatment in patients with AF, it is often underutilized because of increased bleeding complications and frequent monitoring requirements. It has been documented that the left atrial appendage (LAA) is the main source of left atrial thrombus that causes strokes in AF patients. Thus, closure of the LAA may be an effective strategy in stroke reduction. Several devices have been used in closure of the LAA. The WATCHMAN device appears to be a safe and efficacious device for closure of the LAA as recently demonstrated in the PROTECT AF trial.

Original languageEnglish (US)
Pages (from-to)230-233
Number of pages4
JournalCardiology in Review
Volume18
Issue number5
DOIs
StatePublished - Sep 2010
Externally publishedYes

Fingerprint

Atrial Appendage
Atrial Fibrillation
Equipment and Supplies
Stroke
Warfarin
Causality
Anticoagulants
Cardiac Arrhythmias
Thrombosis
Hemorrhage
Therapeutics

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

A novel approach to left atrial appendage exclusion : The WATCHMAN device. / Gorodnitskiy, Alexander; Lucariello, Richard J.; Aizer, Anthony; Coppola, John T.

In: Cardiology in Review, Vol. 18, No. 5, 09.2010, p. 230-233.

Research output: Contribution to journalArticle

Gorodnitskiy, Alexander ; Lucariello, Richard J. ; Aizer, Anthony ; Coppola, John T. / A novel approach to left atrial appendage exclusion : The WATCHMAN device. In: Cardiology in Review. 2010 ; Vol. 18, No. 5. pp. 230-233.
@article{1864fb2246c542af80c357d768455b98,
title = "A novel approach to left atrial appendage exclusion: The WATCHMAN device",
abstract = "Atrial fibrillation (AF), a very common cardiac arrhythmia, is a well-recognized predisposing factor for embolic stroke. While warfarin remains the cornerstone of anticoagulant treatment in patients with AF, it is often underutilized because of increased bleeding complications and frequent monitoring requirements. It has been documented that the left atrial appendage (LAA) is the main source of left atrial thrombus that causes strokes in AF patients. Thus, closure of the LAA may be an effective strategy in stroke reduction. Several devices have been used in closure of the LAA. The WATCHMAN device appears to be a safe and efficacious device for closure of the LAA as recently demonstrated in the PROTECT AF trial.",
author = "Alexander Gorodnitskiy and Lucariello, {Richard J.} and Anthony Aizer and Coppola, {John T.}",
year = "2010",
month = "9",
doi = "10.1097/CRD.0b013e3181e53abb",
language = "English (US)",
volume = "18",
pages = "230--233",
journal = "Cardiology in Review",
issn = "1061-5377",
publisher = "Lippincott Williams and Wilkins",
number = "5",

}

TY - JOUR

T1 - A novel approach to left atrial appendage exclusion

T2 - The WATCHMAN device

AU - Gorodnitskiy, Alexander

AU - Lucariello, Richard J.

AU - Aizer, Anthony

AU - Coppola, John T.

PY - 2010/9

Y1 - 2010/9

N2 - Atrial fibrillation (AF), a very common cardiac arrhythmia, is a well-recognized predisposing factor for embolic stroke. While warfarin remains the cornerstone of anticoagulant treatment in patients with AF, it is often underutilized because of increased bleeding complications and frequent monitoring requirements. It has been documented that the left atrial appendage (LAA) is the main source of left atrial thrombus that causes strokes in AF patients. Thus, closure of the LAA may be an effective strategy in stroke reduction. Several devices have been used in closure of the LAA. The WATCHMAN device appears to be a safe and efficacious device for closure of the LAA as recently demonstrated in the PROTECT AF trial.

AB - Atrial fibrillation (AF), a very common cardiac arrhythmia, is a well-recognized predisposing factor for embolic stroke. While warfarin remains the cornerstone of anticoagulant treatment in patients with AF, it is often underutilized because of increased bleeding complications and frequent monitoring requirements. It has been documented that the left atrial appendage (LAA) is the main source of left atrial thrombus that causes strokes in AF patients. Thus, closure of the LAA may be an effective strategy in stroke reduction. Several devices have been used in closure of the LAA. The WATCHMAN device appears to be a safe and efficacious device for closure of the LAA as recently demonstrated in the PROTECT AF trial.

UR - http://www.scopus.com/inward/record.url?scp=77955874047&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77955874047&partnerID=8YFLogxK

U2 - 10.1097/CRD.0b013e3181e53abb

DO - 10.1097/CRD.0b013e3181e53abb

M3 - Article

C2 - 20699670

AN - SCOPUS:77955874047

VL - 18

SP - 230

EP - 233

JO - Cardiology in Review

JF - Cardiology in Review

SN - 1061-5377

IS - 5

ER -